PE20071004A1 - PHARMACEUTICAL COMPOSITIONS INCLUDING THE COMBINATION OF IVABRADINE AND PERINDROPIL - Google Patents

PHARMACEUTICAL COMPOSITIONS INCLUDING THE COMBINATION OF IVABRADINE AND PERINDROPIL

Info

Publication number
PE20071004A1
PE20071004A1 PE2006001619A PE2006001619A PE20071004A1 PE 20071004 A1 PE20071004 A1 PE 20071004A1 PE 2006001619 A PE2006001619 A PE 2006001619A PE 2006001619 A PE2006001619 A PE 2006001619A PE 20071004 A1 PE20071004 A1 PE 20071004A1
Authority
PE
Peru
Prior art keywords
ivabradine
perindropil
combination
pharmaceutical compositions
compositions including
Prior art date
Application number
PE2006001619A
Other languages
Spanish (es)
Inventor
Vidal Benatar
Guy Lerebours-Pigeonniere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36685870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20071004(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of PE20071004A1 publication Critical patent/PE20071004A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UNA ASOCIACION DE UN INHIBIDOR SELECTIVO Y ESPECIFICO DE LA CORRIENTE SINUSAL I TAL COMO IVABRADINA Y UN AGENTE INHIBIDOR DE CONVERSION DE LA ANGIOTENSINA TAL COMO PERINDOPRIL EN FORMA DE SAL DE TERC-BUTILAMINA O ARGININA EN COMBINACION CON UNO O VARIOS EXCIPIENTES. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE HIPERTENSION ARTERIALREFERS TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ASSOCIATION OF A SELECTIVE AND SPECIFIC INHIBITOR OF SINUS CURRENT I SUCH AS IVABRADINE AND AN INHIBITING AGENT OF ANGIOTENSIN CONVERSION SUCH AS PERINDOPRIL OR COMBAMINE-ARBINE CONVERSION OF THIRD SALT FORM OR SEVERAL EXCIPIENTS. SUCH COMPOSITION IS USEFUL IN THE TREATMENT OF ARTERIAL HYPERTENSION

PE2006001619A 2005-12-21 2006-12-18 PHARMACEUTICAL COMPOSITIONS INCLUDING THE COMBINATION OF IVABRADINE AND PERINDROPIL PE20071004A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513006A FR2894825B1 (en) 2005-12-21 2005-12-21 NOVEL ASSOCIATION OF SINUSAL IF CURRENT INHIBITOR AND CONVERSION ENZYME INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Publications (1)

Publication Number Publication Date
PE20071004A1 true PE20071004A1 (en) 2007-11-17

Family

ID=36685870

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2010001026A PE20110116A1 (en) 2005-12-21 2006-12-18 ASSOCIATION OF IVABRADINE AND PERINDOPRIL AND THE PHARMACEUTICAL COMPOSITION CONTAINING IT
PE2006001619A PE20071004A1 (en) 2005-12-21 2006-12-18 PHARMACEUTICAL COMPOSITIONS INCLUDING THE COMBINATION OF IVABRADINE AND PERINDROPIL

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2010001026A PE20110116A1 (en) 2005-12-21 2006-12-18 ASSOCIATION OF IVABRADINE AND PERINDOPRIL AND THE PHARMACEUTICAL COMPOSITION CONTAINING IT

Country Status (42)

Country Link
US (2) US20070142355A1 (en)
EP (2) EP2298297A1 (en)
JP (2) JP4705564B2 (en)
KR (2) KR100907583B1 (en)
CN (1) CN101015557B (en)
AP (1) AP2119A (en)
AR (1) AR058574A1 (en)
AT (1) ATE508742T1 (en)
AU (1) AU2006252210B2 (en)
BR (1) BRPI0605517A (en)
CA (1) CA2571644C (en)
CO (1) CO5790168A1 (en)
CR (1) CR8820A (en)
CY (1) CY1111575T1 (en)
DK (1) DK1800678T3 (en)
EA (1) EA011253B1 (en)
ES (1) ES2366570T3 (en)
FR (1) FR2894825B1 (en)
GE (1) GEP20094604B (en)
GT (1) GT200600522A (en)
HK (1) HK1106444A1 (en)
HR (1) HRP20110532T1 (en)
IL (1) IL180204A (en)
JO (1) JO2699B1 (en)
MA (1) MA28723B1 (en)
ME (1) ME01958B (en)
MX (1) MXPA06014885A (en)
MY (1) MY146956A (en)
NO (1) NO337640B1 (en)
NZ (1) NZ552221A (en)
PE (2) PE20110116A1 (en)
PL (1) PL1800678T3 (en)
PT (1) PT1800678E (en)
RS (1) RS51731B (en)
SA (1) SA06270480B1 (en)
SG (2) SG133545A1 (en)
SI (1) SI1800678T1 (en)
TW (1) TWI369206B (en)
UA (1) UA86417C2 (en)
UY (1) UY30023A1 (en)
WO (1) WO2007077327A1 (en)
ZA (1) ZA200610824B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894825B1 (en) * 2005-12-21 2010-12-03 Servier Lab NOVEL ASSOCIATION OF SINUSAL IF CURRENT INHIBITOR AND CONVERSION ENZYME INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2920772B1 (en) * 2007-09-11 2009-10-23 Servier Lab ASSOCIATION BETWEEN ANTI-ATHEROTHROMBOTICS AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME
FR2927538B1 (en) * 2008-02-14 2010-02-19 Servier Lab ASSOCIATION OF IF SINUSAL CURRENT INHIBITOR AND BETA BLOCKING.
CN101564394B (en) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 Pharmaceutical composition containing ivabradine and trimetazidine
FR2961105B1 (en) 2010-06-15 2013-02-08 Servier Lab USE OF THE ASSOCIATION OF A SINUSAL IF CURRENT INHIBITOR AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME FOR THE TREATMENT OF CARDIAC INSUFFICIENCY
WO2013116738A1 (en) * 2012-02-03 2013-08-08 Cardeus Pharmaceuticals, Inc. Drug formulations
FR3050380B1 (en) 2016-04-20 2020-07-10 Les Laboratoires Servier PHARMACEUTICAL COMPOSITION COMPRISING A BETA-BLOCKER, A CONVERSION ENZYME INHIBITOR AND AN ANTIHYPERTENSOR OR NSAID.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
DE3736866A1 (en) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K MEANS FOR THE TREATMENT OF HYPERTENSION AND HEART FAILURE
FR2681862B1 (en) * 1991-09-27 1993-11-12 Adir Cie NOVELS (BENZOCYCLOALKYL) ALKYLAMINES, THEIR PREPARATION PROCESS, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE10018401A1 (en) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Medicament for treating hypertrophy-related myocardial disease, containing bradycardic agent, preferably cilobradine, and optionally another cardiac drug
EP1399162A2 (en) * 2001-06-08 2004-03-24 Ortho-McNeil Pharmaceutical, Inc. Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
AR036187A1 (en) * 2001-07-24 2004-08-18 Adir A PROCESS FOR THE PREPARATION OF PERINDOPRIL, ANALOG COMPOUNDS AND ITS SALTS, INTERMEDIARY COMPOUND 2,5-DIOXO-OXAZOLIDINE AND PROCESS TO PREPARE A INTERMEDIARY
WO2003024457A1 (en) * 2001-09-11 2003-03-27 Asahi Kasei Kabushiki Kaisha Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy
FR2834896B1 (en) * 2002-01-23 2004-02-27 Servier Lab ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF IVABRADINE
FR2838648B1 (en) * 2002-04-18 2004-05-21 Servier Lab NEW PERINDOPRIL SALT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
PT1362590E (en) * 2002-07-25 2004-05-31 Boehringer Ingelheim Pharma USE OF CILOBRADINE OR OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE TREATMENT OR PREVENTION OF HEART FAILURE
FR2882554B1 (en) * 2005-02-28 2007-05-04 Servier Lab IVABRADINE HYDROCHLORIDE BETA D-CRYSTALLINE FORM, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2882556B1 (en) * 2005-02-28 2007-05-04 Servier Lab CRYSTALLINE GAMMA D FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2882553B1 (en) * 2005-02-28 2007-05-04 Servier Lab CRYSTALLINE BETA FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2882555B1 (en) * 2005-02-28 2007-05-04 Servier Lab CRYSTALLINE GAMMA FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2894825B1 (en) * 2005-12-21 2010-12-03 Servier Lab NOVEL ASSOCIATION OF SINUSAL IF CURRENT INHIBITOR AND CONVERSION ENZYME INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Also Published As

Publication number Publication date
CN101015557B (en) 2010-12-08
JP2011079854A (en) 2011-04-21
TW200744608A (en) 2007-12-16
NZ552221A (en) 2008-05-30
DK1800678T3 (en) 2011-08-15
WO2007077327A1 (en) 2007-07-12
MXPA06014885A (en) 2009-02-11
JO2699B1 (en) 2013-03-03
CY1111575T1 (en) 2015-10-07
ES2366570T3 (en) 2011-10-21
JP2007169283A (en) 2007-07-05
CA2571644A1 (en) 2007-06-21
ME01958B (en) 2011-10-31
KR100907583B1 (en) 2009-07-14
GT200600522A (en) 2007-07-25
UA86417C2 (en) 2009-04-27
GEP20094604B (en) 2009-02-10
CA2571644C (en) 2011-03-08
FR2894825B1 (en) 2010-12-03
AU2006252210B2 (en) 2012-04-26
CR8820A (en) 2007-08-28
US20070142355A1 (en) 2007-06-21
JP4705564B2 (en) 2011-06-22
AP2006003859A0 (en) 2006-12-31
US20120196850A1 (en) 2012-08-02
EA011253B1 (en) 2009-02-27
EP2298297A1 (en) 2011-03-23
AR058574A1 (en) 2008-02-13
ATE508742T1 (en) 2011-05-15
HK1106444A1 (en) 2008-03-14
AU2006252210A1 (en) 2007-07-05
PL1800678T3 (en) 2011-08-31
KR20090047424A (en) 2009-05-12
IL180204A (en) 2014-02-27
EA200602155A1 (en) 2007-08-31
SA06270480B1 (en) 2011-02-23
RS51731B (en) 2011-10-31
EP1800678B1 (en) 2011-05-11
SI1800678T1 (en) 2011-08-31
NO20065905L (en) 2007-06-22
SG133545A1 (en) 2007-07-30
IL180204A0 (en) 2008-01-20
FR2894825A1 (en) 2007-06-22
MY146956A (en) 2012-10-15
AP2119A (en) 2010-04-21
PT1800678E (en) 2011-07-12
ZA200610824B (en) 2008-06-25
BRPI0605517A (en) 2007-10-16
EP1800678A1 (en) 2007-06-27
HRP20110532T1 (en) 2011-08-31
CN101015557A (en) 2007-08-15
TWI369206B (en) 2012-08-01
NO337640B1 (en) 2016-05-23
PE20110116A1 (en) 2011-03-02
CO5790168A1 (en) 2007-08-31
KR20070066921A (en) 2007-06-27
SG173243A1 (en) 2011-08-29
UY30023A1 (en) 2007-01-31
MA28723B1 (en) 2007-07-02

Similar Documents

Publication Publication Date Title
PE20071004A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING THE COMBINATION OF IVABRADINE AND PERINDROPIL
RS54217B1 (en) Certain triazolopyrazines, compositions thereof and methods of use therefor
PE20142314A1 (en) INTRANASAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
PE20140978A1 (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPINE AND LOSARTAN AND THE PROCESS TO PRODUCE IT
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
PE20181523A1 (en) TREATMENT OF LUPUS NEFRITIS USING LAQUINIMOD
EA200602221A1 (en) NEW APPLICATION OF PEPTIDE CONNECTIONS FOR THE TREATMENT OF PAIN IN TRIGEMINAL NEURALGIA
PE20121442A1 (en) DERIVATIVES OF SUBSTITUTED OXINDOL AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
RS54587B1 (en) Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
CR10748A (en) INDOL COMPOUND
GT200800158A (en) PIRAZOLQUINOLONAS AS POWERFUL PARP INHIBITORS
PA8850801A1 (en) USEFUL COMPOUNDS TO INHIBIT CHK1
PE20090605A1 (en) COMPOSITIONS OF AMMONIA PHENYLALANINE-LIASA PROCARIOTICA AND METHODS OF TREATMENT OF CANCER USING COMPOSITIONS OF THE SAME
EA201100750A1 (en) SUBSTITUTED DIOXOPIPERIDINYL-PHTHALIMIDE DERIVATIVES
TN2010000074A1 (en) Cyclic depsipeptides
AR094074A1 (en) COMPOSITIONS CONTAINING IONS OF STABLE METALS
PE20142318A1 (en) FORMULATIONS OF (+) - 2- [1- (3-ETOXY-4-METOXY-PHENYL) -2-METANSULFONIL-ETIL] -4-ACETTILAMINOISOINDOLIN-1,3-DIONA
CL2011001026A1 (en) Use of pimobedan to prepare a useful medication in the treatment of hypertrophic cardiomyopathy in a cat.
CR20110209A (en) SOLID PHARMACEUTICAL COMPOSITION
EA200901406A1 (en) CLEANING UNIT FOR TOILET
CY1109537T1 (en) Peptides and Peptide Derivatives, PREPARATION OF THESE ALSO USE THESE FOR THE PREPARATION OF THERAPEUTIC AND / OR PREVENTIVE ACTIVE ACTION
PE20120019A1 (en) COMBINATION OF PERINDOPRIL AND N - {[(7S) -3,4-DIMETOXIBICICLO [4.2.0] OCTA-1,3,5-TRIEN-7-IL] METIL} -3- (7,8-DIMETOXI-1, 2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-IL) -N-METHYL-3-OXO-1-PROPANAMINE
CY1111588T1 (en) Substituted Carboxamides as Concentrators of Converter I
RS54185B1 (en) Use of 24-norudca
TR201109686T2 (en) Pharmaceutical Compositions of Olmesartan.

Legal Events

Date Code Title Description
FC Refusal